Home > Result Summaries: Compounds > naratriptan > Result Summary for S2WA1012

Result Summary for S2WA1012

Result Summary

Protocol ID:	S2WA1012
Clinical Study ID:	S2WA1012 (C95-072)
Official Title:	A study to investigate the pharmacokinetics of oral naratriptan in adolescent migraine patients outside a migraine attack.
Phase:	Phase 1
Study Indications or Diseases:	Migraine Disorders
Generic Name:	naratriptan
Trade/Product Name:	amerge;naramig
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Christensen ML: Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine: J.CLIN PHAR 2001;41(2):170-175): Christensen ML: The pharmacokinetics of oral naratriptan in adolescent migraine patients outside of a migraine attack. PHARMACOTHERAPY 1997;17(5):1108-1109.